SHR-1918, a monoclonal antibody against angiopoietin-like 3, in healthy subjects: a randomized, double-blind, placebo-controlled, phase 1 study

被引：0
|
作者：
Xie, Z. [1 ]
Ye, L. [1 ]
Hu, W. [2 ]
Lv, C. [3 ]
Zhu, M. [3 ]
机构：
[1] Guangzhou Med Univ, Affiliated Hosp 2, Guangzhou, Peoples R China
[2] Anhui Med Univ, Hosp 2, Hefei, Peoples R China
[3] Jiangsu Hengrui Pharmaceut Co Ltd, Shanghai, Peoples R China
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
    Goadsby, Peter J.
    Wietecha, Linda A.
    Dennehy, Ellen B.
    Kuca, Bernice
    Case, Michael G.
    Aurora, Sheena K.
    Gaul, Charly
    BRAIN, 2019, 142 : 1894 - 1904
  • [32] Zonisamide improves DLB parkinsonism: A randomized double-blind placebo-controlled phase 3 study
    Murata, M.
    Odawara, T.
    Hasegawa, K.
    Kajiwara, R.
    Takeuchi, H.
    Tagawa, M.
    Kosaka, K.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 185 - 186
  • [33] First-in-human safety, tolerability, and pharmacokinetics of ammoxetine in healthy subjects: a randomized, double-blind, placebo-controlled phase I study
    Shen, Qi
    Hu, Chao
    Miao, Jia
    Chen, Junxia
    Peng, Yueying
    Pan, Tingting
    He, Xiaolin
    Yuan, Jing
    Ni, Shaonan
    Wang, Yongsheng
    Luo, Zhu
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 159
  • [34] Safety, tolerability and pharmacokinetics of WXFL10203614 in healthy Chinese subjects: A randomized, double-blind, placebo-controlled phase I study
    Huang, Kai
    Ding, Ying
    Que, Linling
    Chu, Nannan
    Shi, Yunfei
    Qian, Zhenzhong
    Qin, Wei
    Chen, Yuanxin
    Gu, Xianghong
    Wang, Jiakun
    Zhang, Zhiwei
    Xu, Jianguo
    He, Qing
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [35] Safety, pharmacokinetics and pharmacodynamics of SHR-1703, an innovative long-acting anti-interleukin-5 monoclonal antibody, in healthy subjects: a randomized, double-blind, dose-escalation, placebo-controlled phase I study
    Yang, Ling
    Fang, Yuan
    Luo, Yuan
    Fu, Meng
    Shen, Kai
    Luo, Zhu
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024, 33 (07) : 741 - 752
  • [36] PLACEBO-CONTROLLED, RANDOMIZED, DOUBLE-BLIND STUDY OF INCOBOTULINUMTOXINA FOR SIALORRHEA
    Jost, W.
    Friedman, A.
    Michel, O.
    Oehlwein, C.
    Slawek, J.
    Bogucki, A.
    Ochudlo, S.
    Banach, M.
    Pagan, F.
    Flatau-Baque, B.
    Csikos, J.
    Cairney, C. J.
    Blitzer, A.
    PARKINSONISM & RELATED DISORDERS, 2023, 113 : 40 - 40
  • [37] CETACAINE EFFICACY - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY
    LACHTER, J
    JACOBS, R
    LAVY, A
    SUISSA, A
    WEISLER, A
    EIDELMAN, S
    GASTROENTEROLOGY, 1988, 94 (05) : A245 - A245
  • [38] A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis
    Ratziu, Vlad
    Sheikh, Muhammad Y.
    Sanyal, Arun J.
    Lim, Joseph K.
    Conjeevaram, Hari
    Chalasani, Naga
    Abdelmalek, Manal
    Bakken, Anezi
    Renou, Christophe
    Palmer, Melissa
    Levine, Robert A.
    Bhandari, B. Raj
    Cornpropst, Melanie
    Liang, Wei
    King, Benjamin
    Mondou, Elsa
    Rousseau, Franck S.
    McHutchison, John
    Chojkier, Mario
    HEPATOLOGY, 2012, 55 (02) : 419 - 428
  • [39] Single Dose of SHR-1222, a Sclerostin Monoclonal Antibody, in Healthy Men and Postmenopausal Women With Low Bone Mass: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation, Phase I Study
    Dai, Zhijie
    Fang, Pingfei
    Yan, Xiang
    Zhu, Ronghua
    Feng, Qiong
    Yan, Qiangyong
    Yang, Lingfeng
    Fan, Xiao
    Xie, Yuting
    Zhuang, Lihong
    Feng, Sheng
    Liu, Yantao
    Zhong, Sheng
    Yang, Zeyu
    Sheng, Zhifeng
    Zhou, Zhiguang
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [40] Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies of the Safety, Tolerability and Pharmacokinetics of Naldemedine in Healthy Volunteers
    Fukumura, Kazuya
    Yokota, Takaaki
    Baba, Yuko
    Camilo, Juan
    Ferreira, Arjona
    GASTROENTEROLOGY, 2016, 150 (04) : S537 - S538
12345